nodes	percent_of_prediction	percent_of_DWPC	metapath
Chloropyramine—PTK2—endothelium—systemic scleroderma	0.0814	0.209	CbGeAlD
Chloropyramine—PTK2—blood vessel—systemic scleroderma	0.0751	0.193	CbGeAlD
Chloropyramine—PTK2—Signaling events mediated by focal adhesion kinase—GIT2—systemic scleroderma	0.0474	0.0777	CbGpPWpGaD
Chloropyramine—PTK2—Rac1/Pak1/p38/MMP-2 pathway—TNIP1—systemic scleroderma	0.0392	0.0642	CbGpPWpGaD
Chloropyramine—PTK2—connective tissue—systemic scleroderma	0.0385	0.0988	CbGeAlD
Chloropyramine—PTK2—smooth muscle tissue—systemic scleroderma	0.0352	0.0904	CbGeAlD
Chloropyramine—PTK2—skin of body—systemic scleroderma	0.0348	0.0892	CbGeAlD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—GIT2—systemic scleroderma	0.0319	0.0523	CbGpPWpGaD
Chloropyramine—PTK2—Integrin alphaIIb beta3 signaling—CSK—systemic scleroderma	0.03	0.0492	CbGpPWpGaD
Chloropyramine—PTK2—digestive system—systemic scleroderma	0.0278	0.0714	CbGeAlD
Chloropyramine—PTK2—tendon—systemic scleroderma	0.0265	0.0679	CbGeAlD
Chloropyramine—PTK2—Caspase Cascade in Apoptosis—TOP1—systemic scleroderma	0.0263	0.0431	CbGpPWpGaD
Chloropyramine—PTK2—Apoptosis-related network due to altered Notch3 in ovarian cancer—SMAD7—systemic scleroderma	0.0248	0.0407	CbGpPWpGaD
Chloropyramine—PTK2—Platelet Aggregation (Plug Formation)—CSK—systemic scleroderma	0.0233	0.0382	CbGpPWpGaD
Chloropyramine—PTK2—lung—systemic scleroderma	0.0232	0.0596	CbGeAlD
Chloropyramine—PTK2—Integrins in angiogenesis—CSF1—systemic scleroderma	0.0173	0.0283	CbGpPWpGaD
Chloropyramine—PTK2—Integrins in angiogenesis—COL1A2—systemic scleroderma	0.0158	0.0259	CbGpPWpGaD
Chloropyramine—PTK2—Regulation of actin dynamics for phagocytic cup formation—CD247—systemic scleroderma	0.0155	0.0254	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—RHOB—systemic scleroderma	0.0133	0.0218	CbGpPWpGaD
Chloropyramine—PTK2—Androgen receptor signaling pathway—RHOB—systemic scleroderma	0.0127	0.0208	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CSK—systemic scleroderma	0.0121	0.0198	CbGpPWpGaD
Chloropyramine—HRH1—connective tissue—systemic scleroderma	0.012	0.0308	CbGeAlD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—SMAD7—systemic scleroderma	0.012	0.0196	CbGpPWpGaD
Chloropyramine—PTK2—Fcgamma receptor (FCGR) dependent phagocytosis—CD247—systemic scleroderma	0.0117	0.0192	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—CD247—systemic scleroderma	0.0114	0.0186	CbGpPWpGaD
Chloropyramine—PTK2—Angiogenesis—NOS3—systemic scleroderma	0.0113	0.0185	CbGpPWpGaD
Chloropyramine—HRH1—smooth muscle tissue—systemic scleroderma	0.011	0.0282	CbGeAlD
Chloropyramine—PTK2—CXCR4-mediated signaling events—BLK—systemic scleroderma	0.0105	0.0173	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—CSK—systemic scleroderma	0.0105	0.0173	CbGpPWpGaD
Chloropyramine—PTK2—Integrin-mediated Cell Adhesion—ITGAM—systemic scleroderma	0.0099	0.0162	CbGpPWpGaD
Chloropyramine—PTK2—Angiogenesis—MMP9—systemic scleroderma	0.00904	0.0148	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—COL1A2—systemic scleroderma	0.00873	0.0143	CbGpPWpGaD
Chloropyramine—HRH1—digestive system—systemic scleroderma	0.00868	0.0223	CbGeAlD
Chloropyramine—HRH1—tendon—systemic scleroderma	0.00826	0.0212	CbGeAlD
Chloropyramine—PTK2—Regulation of Actin Cytoskeleton—CSK—systemic scleroderma	0.00765	0.0125	CbGpPWpGaD
Chloropyramine—HRH1—lung—systemic scleroderma	0.00725	0.0186	CbGeAlD
Chloropyramine—PTK2—Syndecan-4-mediated signaling events—MMP9—systemic scleroderma	0.00718	0.0118	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—CSK—systemic scleroderma	0.00716	0.0117	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—RHOB—systemic scleroderma	0.00692	0.0113	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.00668	0.011	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—SELP—systemic scleroderma	0.00657	0.0108	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—COL1A2—systemic scleroderma	0.00652	0.0107	CbGpPWpGaD
Chloropyramine—PTK2—Angiopoietin receptor Tie2-mediated signaling—NOS3—systemic scleroderma	0.00626	0.0103	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—RHOB—systemic scleroderma	0.00613	0.01	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—ITGAM—systemic scleroderma	0.00592	0.00971	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—CSK—systemic scleroderma	0.00558	0.00915	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—MMP2—systemic scleroderma	0.00549	0.00899	CbGpPWpGaD
Chloropyramine—PTK2—Focal Adhesion—BLK—systemic scleroderma	0.00548	0.00898	CbGpPWpGaD
Chloropyramine—PTK2—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—systemic scleroderma	0.0049	0.00802	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—NOS3—systemic scleroderma	0.00453	0.00742	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—RHOB—systemic scleroderma	0.00451	0.0074	CbGpPWpGaD
Chloropyramine—PTK2—LPA receptor mediated events—MMP9—systemic scleroderma	0.00412	0.00676	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—MMP2—systemic scleroderma	0.00403	0.00661	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—MMP1—systemic scleroderma	0.00397	0.00651	CbGpPWpGaD
Chloropyramine—PTK2—Leptin signaling pathway—IL1B—systemic scleroderma	0.00385	0.00631	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—NOS3—systemic scleroderma	0.00384	0.0063	CbGpPWpGaD
Chloropyramine—PTK2—VEGFA-VEGFR2 Pathway—NOS3—systemic scleroderma	0.00341	0.00558	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—SELP—systemic scleroderma	0.00338	0.00555	CbGpPWpGaD
Chloropyramine—PTK2—CXCR4-mediated signaling events—MMP9—systemic scleroderma	0.00332	0.00544	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—RHOB—systemic scleroderma	0.00322	0.00528	CbGpPWpGaD
Chloropyramine—PTK2—Signaling by VEGF—NOS3—systemic scleroderma	0.00322	0.00527	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—RHOB—systemic scleroderma	0.00316	0.00518	CbGpPWpGaD
Chloropyramine—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—systemic scleroderma	0.00309	0.00507	CbGpPWpGaD
Chloropyramine—PTK2—EPH-Ephrin signaling—MMP9—systemic scleroderma	0.00303	0.00497	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—CSK—systemic scleroderma	0.00288	0.00472	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—ITGAM—systemic scleroderma	0.00271	0.00443	CbGpPWpGaD
Chloropyramine—PTK2—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	0.00254	0.00417	CbGpPWpGaD
Chloropyramine—PTK2—EGF/EGFR Signaling Pathway—NOS3—systemic scleroderma	0.00244	0.00401	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—CD247—systemic scleroderma	0.00244	0.00399	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—ITGAM—systemic scleroderma	0.00244	0.00399	CbGpPWpGaD
Chloropyramine—PTK2—Innate Immune System—TNFAIP3—systemic scleroderma	0.00228	0.00374	CbGpPWpGaD
Chloropyramine—PTK2—TGF-beta Signaling Pathway—TGFB1—systemic scleroderma	0.0019	0.00312	CbGpPWpGaD
Chloropyramine—HRH1—G alpha (q) signalling events—EDN1—systemic scleroderma	0.00179	0.00294	CbGpPWpGaD
Chloropyramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—systemic scleroderma	0.0016	0.00263	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CSK—systemic scleroderma	0.00151	0.00247	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MMP2—systemic scleroderma	0.0015	0.00246	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IRF5—systemic scleroderma	0.00148	0.00243	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IRF8—systemic scleroderma	0.00142	0.00232	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD247—systemic scleroderma	0.00142	0.00232	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—ITGAM—systemic scleroderma	0.00142	0.00232	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—SMAD7—systemic scleroderma	0.00138	0.00227	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—MMP1—systemic scleroderma	0.00136	0.00222	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—TNFAIP3—systemic scleroderma	0.00133	0.00218	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—BLK—systemic scleroderma	0.00131	0.00215	CbGpPWpGaD
Chloropyramine—PTK2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	0.00126	0.00207	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—systemic scleroderma	0.00119	0.00194	CbGpPWpGaD
Chloropyramine—PTK2—Axon guidance—MMP9—systemic scleroderma	0.00113	0.00185	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CTLA4—systemic scleroderma	0.00108	0.00176	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—RHOB—systemic scleroderma	0.00107	0.00176	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MMP2—systemic scleroderma	0.00107	0.00175	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—HSPG2—systemic scleroderma	0.00101	0.00166	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—RHOB—systemic scleroderma	0.001	0.00164	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—NOS3—systemic scleroderma	0.000983	0.00161	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CSK—systemic scleroderma	0.000976	0.0016	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—RHOB—systemic scleroderma	0.000908	0.00149	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—EDN1—systemic scleroderma	0.000903	0.00148	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—HLA-DQB1—systemic scleroderma	0.000886	0.00145	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL1A—systemic scleroderma	0.000841	0.00138	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—CD40LG—systemic scleroderma	0.000836	0.00137	CbGpPWpGaD
Chloropyramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic scleroderma	0.000811	0.00133	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—MMP9—systemic scleroderma	0.000804	0.00132	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—SMAD7—systemic scleroderma	0.000693	0.00114	CbGpPWpGaD
Chloropyramine—PTK2—Developmental Biology—TGFB1—systemic scleroderma	0.000663	0.00109	CbGpPWpGaD
Chloropyramine—PTK2—Hemostasis—TGFB1—systemic scleroderma	0.00065	0.00107	CbGpPWpGaD
Chloropyramine—HRH1—GPCR ligand binding—CCL2—systemic scleroderma	0.000618	0.00101	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—EDN1—systemic scleroderma	0.000547	0.000896	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—RHOB—systemic scleroderma	0.000536	0.000879	CbGpPWpGaD
Chloropyramine—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	0.000511	0.000837	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	0.000506	0.000829	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CSK—systemic scleroderma	0.000489	0.000801	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	0.000464	0.00076	CbGpPWpGaD
Chloropyramine—PTK2—Immune System—IL1B—systemic scleroderma	0.000439	0.000719	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—CCL2—systemic scleroderma	0.000374	0.000613	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—NOS3—systemic scleroderma	0.000333	0.000546	CbGpPWpGaD
Chloropyramine—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	0.000317	0.000519	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—EDN1—systemic scleroderma	0.000274	0.000449	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—MMP9—systemic scleroderma	0.000267	0.000438	CbGpPWpGaD
Chloropyramine—PTK2—Signaling Pathways—TGFB1—systemic scleroderma	0.00022	0.000361	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—CCL2—systemic scleroderma	0.000187	0.000307	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—NOS3—systemic scleroderma	0.000167	0.000273	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—MMP9—systemic scleroderma	0.000134	0.000219	CbGpPWpGaD
Chloropyramine—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	0.00011	0.000181	CbGpPWpGaD
